drugset / Trial / NCT01041911

To Evaluate the Dose Response of 3 Doses of Euphorbia Prostrata in Patients With First and Second Degree Hemorrhoids

NCT01041911 ↗

Phase 2 Completed 102 enrolled Panacea Biotec Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safe and efficacious dose of Euphorbia prostrata for control of per rectal bleeding in patients with first and second degree hemorrhoids.

Timeline

Start
2010-03
Primary completion
2010-10
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Euphorbia prostrata Unknown 50 mg —
Comparator Euphorbia prostrata Unknown 100 mg —
Comparator Euphorbia prostrata Unknown 200 mg —

Indications